Source: The Business Journals: San Antonio

CytoBioscience: CytoBioscience CEO: Going public will speed growth

The Alamo City company expects to gain greater access to new capital and more business opportunities.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
James Garvin's photo - CEO of  CytoBioscience

CEO

James Garvin

CEO Approval Rating

79/100

Read more